The device allows researchers to track cancer growth for a longer period of time, enabling improved observations and analysis, according to the researchers.
The company is providing several of its Parsortix instruments to the CANCER-ID consortium as part of an effort to establish liquid biopsy in routine clinical practice.
The agency is sending an Oxford Nanopore MinIon to the International Space Station to determine if the technology's microfluidic system can work in microgravity.
The aim of the project, called Metafluidics, is to replace cumbersome conventional approaches with a cheaper, faster, and higher-throughput microfluidics platform.
